Cologuard Plus: Key Advancement in Colorectal Cancer Screening
Discover the Cologuard Plus Test
The FDA has recently approved Cologuard Plus for screening colorectal cancer in adults 45 years and older who are at average risk. This groundbreaking test uses non-invasive methods to detect hypermethylated DNA markers, providing a valuable tool for early cancer detection.
Why Cologuard Plus is Important
Colorectal cancer is one of the leading causes of cancer-related deaths. Regular screening is crucial for early identification and treatment. Cologuard Plus increases accessibility to screening, encouraging more individuals to participate and get tested.
- Non-invasive sampling
- Increased detection rates
- Convenient home collection
How to Prepare for Cologuard Plus
- Consult your doctor about your screening options.
- Follow any pre-screening dietary restrictions.
- Ensure you understand how to collect the sample correctly.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.